文献速递慢病防控与筛查卫生政策与健康促进

欧洲神经系统疾病负担:2017年全球疾病负担研究分析

The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 2017.
PubMed 文献 · Lancet Public Health · 2020-01-01

该研究基于GBD 2017数据,比较欧盟与WHO欧洲区域及全球1990–2017年神经系统疾病负担。卒中、痴呆和头痛是欧盟DALYs三大原因。

要点

  • 卒中、痴呆和头痛是欧盟DALYs三大原因,卒中亦为WHO欧洲区域首位原因。
  • 全年龄负担增加但年龄标化负担多数国家下降,主要归因于过早死亡减少。

核心结论

  • 神经系统疾病是欧盟残疾和过早死亡的第三大原因,其患病率和负担可能随欧洲人口老龄化而增加。
  • 卫生当局需更加重视神经系统疾病的预防和照护,不同国家在卫生服务发展和资源分配上应有不同优先事项。

研究设计与样本

  • 基于GBD 2017研究,计算欧盟和WHO欧洲区域2017年神经系统疾病的发病率、患病率、死亡率、DALYs、YLLs和YLDs。
  • 分析疾病包括阿尔茨海默病及其他痴呆、癫痫、头痛(偏头痛和紧张型头痛)、多发性硬化、帕金森病、脑癌、运动神经元病、神经感染性疾病和卒中。
  • 数据按性别、年龄、年份、地点和社会人口背景呈现为计数和率,并比较1990–2017年欧盟与WHO欧洲区域及全球的负担。

主要发现

  • 欧盟DALYs三大原因为卒中、痴呆和头痛;卒中亦为WHO欧洲区域DALYs首位原因。
  • 研究期间神经退行性疾病全年龄负担大幅增加,尽管卒中和感染率大幅下降;欧洲神经系统疾病负担男性高于女性,在80–84岁人群达峰,且随WHO欧洲区域和国家差异显著。

临床怎么用

  • 欧盟应将神经系统疾病作为第三大残疾和过早死亡原因纳入公共卫生优先事项,加强预防和照护资源配置。
  • 鉴于卒中、痴呆和头痛是欧盟DALYs主要贡献者,防控策略应优先针对这三类疾病。
  • 各国神经系统疾病负担差异显著,卫生服务发展和资源分配需结合本国具体负担制定优先事项。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Neurological disorders account for a large and increasing health burden worldwide, as shown in the Global Burden of Diseases (GBD) Study 2016. Unpacking how this burden varies regionally and nationally is important to inform public health policy and prevention strategies. The population in the EU is older than that of the WHO European region (western, central, and eastern Europe) and even older than the global population, suggesting that it might be particularly vulnerable to an increasing burden of age-related neurological disorders. We aimed to compare the burden of neurological disorders in the EU between 1990 and 2017 with those of the WHO European region and worldwide. METHODS: The burden of neurological disorders was calculated for the year 2017 as incidence, prevalence, mortality, disability-adjusted life-years (DALYs), years of life lost, and years lived with disability for the countries in the EU and the WHO European region, totally and, separately. Diseases analysed were Alzheimer's disease and other dementias, epilepsy, headache (migraine and tension-type headache), multiple sclerosis, Parkinson's disease, brain cancer, motor neuron diseases, neuroinfectious diseases, and stroke. Data are presented as totals and by sex, age, year, location and socio-demographic context, and shown as counts and rates. FINDINGS: In 2017, the total number of DALYs attributable to neurological disorders was 21·0 million (95% uncertainty interval 18·5-23·9) in the EU and 41·1 million (36·7-45·9) in the WHO European region, and the total number of deaths was 1·1 million (1·09-1·14) in the EU and 1·97 million (1·95-2·01) in the WHO European region. In the EU, neurological disorders ranked third after cardiovascular diseases and cancers representing 13·3% (10·3-17·1) of total DALYs and 19·5% (18·0-21·3) of total deaths. Stroke, dementias, and headache were the three commonest causes of DALYs in the EU. Stroke was also the leading cause of DALYs in the WHO European region. During the study period we found a substantial increase in the all-age burden of neurodegenerative diseases, despite a substantial decrease in the rates of stroke and infections. The burden of neurological disorders in Europe was higher in men than in women, peaked in individuals aged 80-84 years, and varied substantially with WHO European region and country. All-age DALYs, deaths, and prevalence of neurological disorders increased in all-age measures, but decreased when using age-standardised measures in all but three countries (Azerbaijan, Turkmenistan, and Uzbekistan). The decrease was mostly attributed to the reduction of premature mortality despite an overall increase in the number of DALYs. INTERPRETATION: Neurological disorders are the third most common cause of disability and premature death in the EU and their prevalence and burden will likely increase with the progressive ageing of the European population. Greater attention to neurological diseases must be paid by health authorities for prevention and care. The data presented here suggest different priorities for health service development and resource allocation in different countries. FUNDING: European Academy of Neurology.

来源:Lancet Public Health,查看原文。版权归原作者所有。

引用

  1. Deuschl G, Beghi E, Fazekas F, et al. The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 2017. Lancet Public Health. 2020. PMID: 33007212. doi:10.1016/S2468-2667(20)30190-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。